This topic contains a solution. Click here to go to the answer

Author Question: When will a patient who has received ibritumomab tiuxetan with yttrium-90 (IT-Y90) reach the ... (Read 39 times)

sheilaspns

  • Hero Member
  • *****
  • Posts: 567
When will a patient who has received ibritumomab tiuxetan with yttrium-90 (IT-Y90) reach the hematologic nadir?
 
  1. During days 5-10
  2. 10-14 days after infusion
  3. In 30 days
  4. In 7-9 weeks

Question 2

To help minimize side effects in a cancer patient receiving interferon-alfa therapy, the nurse should:
 
  1. start oxygen.
  2. lower the ambient temperature.
  3. provide antiemetics.
  4. administer acetaminophen.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meow1234

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Correct Answer: 4

Answer to Question 2

Correct Answer: 4




sheilaspns

  • Member
  • Posts: 567
Reply 2 on: Jul 23, 2018
Gracias!


Bigfoot1984

  • Member
  • Posts: 321
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

For a complete list of videos, visit our video library